pharmaceutical investing Cytokinetics and Astellas Provide Updates Regarding Collaborative Skeletal Muscle Program
pharmaceutical investing Approval of Linzess Tablets 0.25 mg in Japan for Additional Indication of Chronic Constipation
NextSource Materials Signs Agreement for the Supply of Graphite Fines as Additional Source of Feedstock for its Battery Anode Facility in Abu Dhabi
